On the whole, however, Ro focuses on providing FDA-approved brand name medications
[113] Healthcare providers should consider the patients previous corticosteroid exposure, concurrent medications, and underlying health conditions when determining appropriate dosing
Cardiovascular health assessment, especially for PT-141
Dynamic transcriptional responses to injury of regenerative and non-regenerative cardiomyocytes revealed by single-nucleus RNA sequencing
Footnotes 1.^Press release Boehringer Ingelheim, February 19, 2019
Recent studies have claimed clinical benefits in patients with heart and kidney failure, arthritis, and sleep apnea disorders, mediated in part through anti-inflammatory and metabolic pathways, with some benefits partly independent of the degree of weight loss achieved